TTNP Titan Pharmaceuticals Inc.

-0.04  -2%
Previous Close 1.7
Open 1.7
Price To Book 3.26
Market Cap 22297474
Shares 13,413,628
Volume 101,177
Short Ratio
Av. Daily Volume 962,876

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 treatment has commenced - noted October 11, 2017. DSMB recommended trial to continue - July 2, 2018 but further enrollment has been postponed due to lack of resources.
Ropinirole implant
Parkinson's disease
CRL issued April 30, 2013. Approved May 26 2016
Opioid dependence

Latest News

  1. Knight Therapeutics: Use of PROBUPHINE™ for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast
  2. TTNP: EMA Approval of Probuphine Expected 2Q:19
  3. Edited Transcript of TTNP earnings conference call or presentation 2-Apr-19 12:30pm GMT
  4. Titan Pharmaceuticals: 4Q Earnings Snapshot
  5. Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results
  6. Titan Pharmaceuticals Partners With AppianRx To Provide Comprehensive Probuphine® Patient Support Services
  7. Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019
  8. 4 Healthcare Stocks Looking To Kick Off A Strong Week
  9. Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®
  10. TTNP: Shipments Spike in 2H:18
  11. 4 Healthcare Stocks Looking To Start February Off Strong
  12. Why Titan Pharmaceuticals Is Soaring Today
  13. How Many Insiders Bought Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Shares?
  14. Why Titan Pharmaceuticals Stock Is Skyrocketing Today
  15. Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc.
  16. Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch
  17. Titan Pharmaceuticals Announces Reverse Stock Split
  18. Edited Transcript of TTNP earnings conference call or presentation 14-Nov-18 9:15pm GMT
  19. Alternatives to Watch
  20. Factors of Influence in 2018, Key Indicators and Opportunity within Atlantic American, Titan Medical, Adial Pharmaceuticals, Aptinyx, Sotherly Hotels, and Titan Pharmaceuticals — New Research Emphasizes Economic Growth